What is already known about this subject
Carotegrast methyl (AJM300) is the first orally administrable small
molecule of α4-integrin antagonist to be approved for the treatment of
ulcerative colitis.
Carotegrast methyl inhibits CYP3A4 time-dependently in vitro.